Comparing GLP-1 options when coverage changes If your Anthem coverage changes, you may need to switch between medications
Regular clinical review ensures treatment safety, optimises therapeutic outcomes, and allows timely identification and management of any complications or adverse effects
Administering semaglutide injections requires precision in both location and technique to maximize therapeutic benefit and minimize complications
The global kidney patient trials network and the captivate platform clinical trial design: a trial protocol
Serge Jabbour from Thomas Jefferson University in Philadelphia, Pennsylvania, and colleagues aimed to describe the clinical course in terms of body weight, glycemic outcomes, and adverse events during the first 12 weeks following a switch from GLP-1 receptor agonists directly to tirzepatide 5 mg in a prospective study
For patients who anticipate stopping treatment, lifestyle changes during the medicated weight-loss period (diet quality improvements, regular exercise habits, sleep hygiene) may help preserve some of the BP benefit even if weight rebounds partially